In postanoxic coma after cardiac arrest (CA), the electroencephalogram (EEG) is indispensable for the evaluation of the severity of the brain injury and the early diagnosis of nonconvulsive status epilepticus (NCSE). Hypoxic NCSE that may significantly contribute to the coma, but also severe and irreversible, near‐terminal brain anoxia (BA), are commonly associated with nonevolving generalized periodic epileptiform discharges (GPEDs), defined as bilateral, synchronous, and symmetric spikes or spike--wave complexes with relative uniform morphology and duration, a quantifiable interdischarge interval between consecutive waveforms, and recurrence of the waveform at nearly regular intervals.[1](#epi412073-bib-0001){ref-type="ref"} Recognition of NCSE primarily relies on GPED frequency, assessed by visual inspection. Whereas a diagnosis of NCSE can be made with frequencies \> 2.5 Hz, an additional criterion is required for slower frequencies, namely both EEG and clinical improvement after intravenous (IV) administration of a rapidly acting antiepileptic drug (AED). EEG improvement alone only suggests possible NCSE.[2](#epi412073-bib-0002){ref-type="ref"} By implication, slow GPEDs that fail to meet the criteria of possible NCSE are considered an epiphenomenon of BA. Although the postanoxic occurrence of GPEDs carries poor prognosis,[3](#epi412073-bib-0003){ref-type="ref"} and some authors believe that aggressive treatment may not be warranted in such patients,[4](#epi412073-bib-0004){ref-type="ref"} AED treatment has been associated with grade 3 cerebral performance outcome grade in some patients with possible NCSE.[5](#epi412073-bib-0005){ref-type="ref"}

In clinical practice, slow (≤2.5 Hz) GPEDs present a particularly difficult diagnostic challenge. Some patients with EEG but not clinical improvement after IV AED may be diagnosed with possible NCSE for reasons that may include heavy pharmacological suppression, coexisting sepsis or metabolic derangements, a degree of secondary (potentially reversible) cerebral edema, comorbidities like dementia, or simply insufficient noxious stimulation. Some of these factors may also account for the abnormal EEG background sometimes seen after a partial EEG response. Moreover, a diagnosis of possible NCSE may be missed when the dose of IV AED is insufficient to block GPEDs, or when GPEDs are not responsive to benzodiazepines but only to temporary propofol withdrawal, which may not be routinely attempted.[6](#epi412073-bib-0006){ref-type="ref"} Very low (i.e., \<2 Hz) frequencies may sometimes discourage vigorous diagnostic maneuvers.

Efforts to bypass such constraints have focused on the GPED morphology, but discrimination between "epileptic" (associated with NCSE) and "nonepileptic" (associated with BA) GPEDs appears impossible at the individual patient level.[6](#epi412073-bib-0006){ref-type="ref"}, [7](#epi412073-bib-0007){ref-type="ref"} We used event‐related computational methods to study "slow" GPED microstructure, aiming to detect possible characteristic features that could assist early differentiation between possible NCSE presumably contributing to coma and BA.

Methods {#epi412073-sec-0002}
=======

Patient groups {#epi412073-sec-0003}
--------------

We investigated GPEDs in three groups of comatose post‐CA patients (Table [1](#epi412073-tbl-0001){ref-type="table-wrap"}). Group 1 includes two patients, diagnosed with NCSE on the basis of \>2.5 Hz GPEDs in the first postinsult video‐EEG (2/2), EEG (1/1) and clear clinical response (1/1) to IV AED, and final resolution of the NCSE with normalization or near‐normalization of the biological EEG rhythms and clinical improvement. All patients in groups 2 and 3 had ≤2.5‐Hz GPEDs on their first EEG. In group 2 (six patients), the diagnosis of possible NCSE contributing to coma was based on clear EEG (but not clinical) responses to acute IV AED/temporary propofol withdrawal (five of five; see also Fig. [S1](#epi412073-sup-0001){ref-type="supplementary-material"}), or aggressive escalation of IV AED (1/1). In the five patients of group 3, GPEDs were deemed to reflect terminal BA, because none showed any EEG or clinical improvement to IV AED/propofol maneuver. There was no difference in terms of comorbidities or AED treatment between the patients of groups 2 and 3; all received IV levetiracetam, phenytoin, or valproate acid in comparable doses. All patients underwent 24‐h therapeutic hypothermia or active normothermia (multicenter Target Temperature Management trial,[8](#epi412073-bib-0008){ref-type="ref"} ethics approval registered at ClinicalTrials.gov NCT01020916).

EEG recordings {#epi412073-sec-0004}
--------------

Computational analysis was performed on the first postinsult EEGs, performed in the intensive care unit of St. Thomas' Hospital, London, United Kingdom (EEG methodology is provided in the Supplementary Material).

Event selection and analysis {#epi412073-sec-0005}
----------------------------

All patients had GPEDs that were nonevolving in frequency, morphology, or location.[1](#epi412073-bib-0001){ref-type="ref"}, [2](#epi412073-bib-0002){ref-type="ref"} GPED frequencies were nearly regular in all EEGs, with maximum fluctuations not exceeding 0.8 Hz (Table [1](#epi412073-tbl-0001){ref-type="table-wrap"}).

For each patient, all artifact‐free GPED events were visually annotated at the peak of the first maximal in amplitude negative phase using precise time markers. A minimum period of 5 seconds between marked events was left without annotations to avoid overlap in the event‐related averaging analysis. The morphology of the GPED waves was estimated via time averaging in the electrodes where the GPEDs were more prominent according to the calculated voltage maps.

Event‐related data were further processed by a custom‐made MATLAB‐based (MathWorks, Natick, MA, U.S.A.) software suite developed at the Neurophysiology Unit, School of Medicine, University of Patras, Greece. Scalp voltage mapping of the annotated events was performed by the use of multiquadric interpolation based on Green\'s function method[9](#epi412073-bib-0009){ref-type="ref"} after baseline correction of all channels. Additionally, the annotated events were time‐averaged and superpositioned within a time window of −0.50 to 0.50 s, centered at time = 0.00.

###### 

Clinical and EEG features of patients

               Patients/sex/age   Reactivity        Outcome[a](#epi412073-note-0002){ref-type="fn"}                GPEDs frequency (Hz)     GPEDs Amplitude (uV)              
  ------------ ------------------ ----------------- -------------------------------------------------------------- ------------------------ ---------------------- ---------- --------
  Group 1                                                                                                                                                                     
  Patient 1    1 / F / 52         None              N/A                                                            N/A                      3                      2.5--3.0   −275.6
  Patient 2    2 / M / 55         DZP               GPEDs ceased; θ, α and β                                       Opened eyes to command   2                      2.5--3.0   −187
  Group 2                                                                                                                                                                     
  Patient 3    3 / M / 63         LRZ               GPEDs ceased; δ, θ, α and β                                    No                       3                      1.5--2     −55.69
  Patient 4    4 / M / 62         CNZ               GPEDs ceased; δ and θ                                          No                       3                      0.8--1.5   −34.8
  Patient 5    5 / M / 60         Propofol window   GPEDs ceased; δ and θ, some α                                  No                       5                      1          −110.7
  Patient 6    6 / M / 60         None              N/A[b](#epi412073-note-0003){ref-type="fn"}                    No response              3                      1.2--2.0   −83
  Patient 7    7 / M / 71         DZP               GPEDs ceased; δ and θ, some α                                  No                       3                      1.2--1.8   −130.6
  Patient 8    8 / M / 70         Propofol window   No physiological rhythms, but focal frontal seizure activity   No                       5                      0.8--1.2   −74.8
  Group 3                                                                                                                                                                     
  Patient 9    8 / M / 58         LRZ               No Effect                                                      No response              3                      1.5--2.0   −86.4
  Patient 10   9 / M / 78         LRZ               No Effect                                                      No response              5                      0.7--1.5   −242.5
  Patient 11   10 / M / 36        MDZ               N/A                                                            No response              5                      1--1.5     −174.3
  Patient 12   11 / M / 33        Propofol window   No Effect                                                      No response              5                      1--1.5     −221.5
  Patient 13   13 / M / 81        Propofol window   No Effect                                                      No response              5                      1.6--1.8   −62.7

DZP, diazepam; LRZ, lorazepam; CNZ, clonazepam; MDZ, midazolam; GPED, generalized periodic epileptiform discharges.

Glasgow‐Pittsburgh Cerebral Performance Categories.

Complete resolution of GPEDs with emergence of θ and α rhythms was recorded two days later after AED increased from LEV 500bd IV to LEV 1500bd and VPA 300bd, both IV.
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Results {#epi412073-sec-0006}
=======

A total of 508, 678, and 589 GPED events were obtained for groups 1, 2, and 3 respectively.

Voltage scalp maps {#epi412073-sec-0007}
------------------

The topography of the negative phase of the GPEDs differed between the patients with NCSE (group 1) and those with BA (group 3). In all patients of group 1, the maximum peak of the negative GPED phase was localized over the prefrontal and superior frontal areas (Fig. [1](#epi412073-fig-0001){ref-type="fig"}, left panel), whereas in all patients with BA it was localized over the parietal and occipital areas (Fig. [1](#epi412073-fig-0001){ref-type="fig"}, right panel). All patients of group 2 (with possible NCSE) showed voltage map topographies similar to those with NCSE (Fig. [1](#epi412073-fig-0001){ref-type="fig"}, middle panel).

![Voltage maps of the maximum negative phase of the averaged generalized periodic epileptiform discharges (GPEDs). For the possible nonconvulsive status epilepticus--related groups 1 and 2, the negative phase of the GPEDs is maximal over the frontal areas, whereas for the patients with anoxic damage (group 3), it is maximal over the posterior areas.](EPI4-2-472-g001){#epi412073-fig-0001}

GPED morphology {#epi412073-sec-0008}
---------------

Morphology, amplitude, and duration of the GPED complexes varied inconsistently among patients within each group and across the three groups without characteristic features that could differentiate between NCSE and BA (Table [1](#epi412073-tbl-0001){ref-type="table-wrap"}, Fig. [S2](#epi412073-sup-0002){ref-type="supplementary-material"}).

Discussion {#epi412073-sec-0009}
==========

Nonevolving GPEDs are highly associated with NCSE,[10](#epi412073-bib-0010){ref-type="ref"} but they may also be "nonepileptic" as in metabolic and other encephalopathies. In postanoxic coma after CA, slow nonevolving GPEDs may still signal possible NCSE contributing to coma, or be "nonepileptic," reflecting terminal anoxic damage.

We herein provide neurophysiological evidence, according to which an anterior localization of the maximum GPED negativity is a possible distinctive biomarker for NCSE‐related GPEDs, differentiating them from "nonepileptic" GPEDs of comparable morphology but posterior location of the major negative phase. The reason for such anterior emphasis for the "epileptic" GPEDs in postanoxic coma is unknown; perhaps one could draw a parallel with the also frontally dominant EEG discharges in generalized epilepsies and their relation to arousal mechanisms,[11](#epi412073-bib-0011){ref-type="ref"} allowing a tentative hypothesis of still intact anterior corticothalamic circuits that are responsible for arousal mechanisms.

We emphasize that anterior topography of maximal negativity of slow postanoxic GPEDs may only indicate the possibility of NCSE, but not the degree to which the latter may contribute to the coma. Moreover, its usefulness at the individual patient level, as shown in this report, has to be confirmed in a larger number of carefully studied patients. Notwithstanding these limitations, this preliminary evidence suggests that studying the EEG microstructure by voltage mapping and possibly other computational methods may reveal important biomarkers to assist the classical clinical and EEG diagnosis of NCSE.
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==========
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###### 

**Figure S1.** Patient 8 (group 2). (**A**) A 2‐Hz generalized periodic epileptiform discharge (GPEDs) pattern on sedation with propofol. (**B**) Temporary discontinuation of propofol resulted in the brief frontal seizure discharges interspersing the GPEDs pattern.

###### 

Click here for additional data file.

###### 

**Figure S2.** Generalized periodic epileptiform discharge (GPEDs) morphology. Time‐average and superposition plots for the prominent GPEDs wave of each patient are shown.

###### 

Click here for additional data file.

###### 

**Appendix S1.** EEG recording and setup.

###### 

Click here for additional data file.
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